Week 435 Review - A good week and some more Optibiotix profit taken.

A really good week for most of the portfolio, and some more OPTI:Optibiotix profits banked in a fit of pique when GAW:Games Workshop tanked so I wanted to buy some more. The result was an improvement in the deficit between cost and value of £1,613 to £94,818 and an increase in portfolio value to £108,900.

GAW:Games Workshop was the worst performer, with an unbelievable 15% drop following a half-yearly trading update that was pretty good. Even if Q2 was slightly down on expectations, it didn't justify a 15% drop in share price. My holding that was 10% up is now 6% down, which is utterly devastating as it means nearly all my magic formula shares are losing money. I'm so convinced this is a case of manipulation I bought some more.

PAF:Pan African Resources dropped 9% thus contributing to my theory that I curse every stock I invest in, but I get the dividend next week which is a nice Christmas present.

EDV:Endeavour Mining dropped 7% demonstrating that all the gold miners took a bit of a hit despite the gold price staying above $2,000. These have dropped way, way down my magic formula list so I've put in a limit order to sell them, but it's 21% higher than the current price.

FXPO:Ferrexpo dropped 5% but I've given up worrying about these until the war in Ukraine is sorted.

SAE:Simec Atlantis Energy also dropped 5% but it hardly affects the value of my holding.

PLUS:Plus 500 went up 5% but my original holding is still 17% down. My recent SIPP purchase is  7% up though, so a rare bit of good timing.

IGG:IG Group is slowly dragging itself back up, climbing 6% so my holding is now 17% down. I've received 13% in dividends, so it's not doing that bad. I should probably increase my holding.

ASHM:Ashmore Group have been having a torrid time lately, but a 10% increase this week means my holding is now 30% down, or 23% down if you take off the 7% dividends.

BLU:Blue Star Capital went up 14% but that's 0.01p and utterly meaningless.

PBX:Probiotix Health climbed 1p after sitting on 5p for months, so a 20% rise is worth about £1,000 of my increase this week. My holding is still 72% down on the IPO price when I was given the shares as a dividend.

Share of the Week is AJB:AJ Bell which climbed a whopping 23% after great results. Unfortunately my holding is only £250 as I've just started buying them as my monthly investment, so it was in my interest for the share price to stay low for 3 months. This month's investment is on Monday, so I'll be buying on a spike and no doubt will lose out. I nearly switched the investment to something else, but there's a chance the share has re-rated and will continue upwards, as it's still way below the share price from a few years ago.

Here's the ISA and shares portfolio after week 19 of year 9.

			Weekly Change
Cash	£205.92		+£40.32
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£50,740.72	(-48.8%)	+£1,043.74
Potential profits	£2,135.79		-£11.23
Yr 9 Dividends	£191.08		+£44.07
Yr 9 Interest	£2.46		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£37.07	(0.6%)	+£7.65
Total Dividends	£12,102.51		+£44.07
Total Interest	£4.39		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£288.85	(4.9%)	-£0.26
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I got a £44 dividend from ASHM:Ashmore Group and much of the value increase was thanks to the 1p rise in PBX:Probiotix Health and 0.5p rise in OPTI:Optibiotix. Potential profits dropped as GAW:Games Workshop plummeted to loss, meaning my cheapest OPTI holding is the only thing left in profit in the entire ISA, and you could describe that as creative accounting given the huge losses in my other OPTI purchases. Cash went up less than the dividend due to monthly fees.

I also got 3p following a MAIS:Maistro share consolidation which leaves me with 1 share. That share cost me £124 and is worth about 10p and is not tradeable, so not surprisingly I wrote these off a long time ago.

Quite pleased that after 19 weeks I'm showing a projected profit of £37 a month from dividends alone, especially as I never used to have any dividends in my ISA.

Slight tick upwards.

Still below the trend line, but at least moving towards it.

The SIPP looks like this after week 419 overall and week 3 of year 9.

			Weekly Change
Cash	£557.71		+£233.34
Portfolio cost	£101,776.51		+£628.69
Portfolio sell value (bid price - commission)	£56,139.91	(-44.8%)	+£564.50
Potential profits	£1,906.92		-£433.10
Yr 9 Dividends	£13.99		+£0
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£1,999.45		+£636.51
Yr 9 proj avg monthly profit	£2,884.24	(50.7%)	-£99.10
Total Dividends	£14,648.87		+£0
Total Interest	£5.93		+£0
Total Profit from sales	£12,835.35		+£636.51
Average monthly cash profit	£272.16	(4.8%)	+£5.77
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	39%		+1%

Cash went up because I paid in my £250 monthly investment and it hasn't been spent yet, minus £16 monthly fees. 

I sold 3,932 OPTI:Optibiotix shares that I bought at 9.56p and got 26.355p making £636.52 (159.2%) profit and liberated £1,024.33. I used that to buy 11 shares in GAW:Games Workshop at 9086.856p costing £1,016.50. They went up to 9145p so are just down on commission now. A big dividend is due in January.

Sell value went up less than the ISA due to the profit taking, and good that potential profits fell less than the profits I took. Year 9 performance looks amazing because we're only on week 3, so I know there's no way I can keep that up. Long term performance only improved by 0.1% as a result of the sale. It's going to take me a long time to recover from DDDD:4D Pharma going bust.

Similar to the ISA - hoping this is the start of a little Santa rally as there's been absolutely no sign of it up till now.

Running parallel to the trend line, but need to get back above it.

The trading account looks like this after week 385 overall and week 21 of year 8.

			Weekly Change
Cash	£141.20		+£0
Portfolio cost	£1,935.11		+£0
Portfolio sell value (bid price - commission)	£1,094.57	(-43.4%)	+£5.24
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£60.37	(+37.4%)	-£3.01
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.51	(-4.0%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

The small gains in JLP:Jubilee Metals and BARC:Barclays were mostly wiped out by the drop in SBTX:SkinBioTherapeutics, but the value went up by £5.

So flat

So far below the trend line

I still have £1,500 I could liberate from my 9.56p OPTI:Optibiotix holding so I am tempted to get another £1,000 for a dividend paying share, and IGG:IG Group are the current favourites as they have a generous dividend and seem to be recovering. The alternative is to look to my new magic formula rankings, which rates IPX:Impax Asset Management Group as the 2nd best stock after PLUS:Plus 500. They pay their dividend in March after a February ex-date, as do IGG, but I'm tempted to give IPX a try.

I won't get another work pension transfer until the end of February so can only buy new dividend shares if I sell something. Many of my original magic formula shares are now outside the top 30 ranking, so I should really sell them and buy something in the top 30. Unfortunately they are mostly making a loss. However, ANTO:Antofagasta went into profit this week. I've only had a feeble £5 dividend from them and nothing due till April, and they are ranked 61. Ideally I'd like them to climb around 6% before I sell, but I may be better off selling for a minuscule profit and getting IPX now...

Week 434 Review - Bad week but cashed in some profits selling a few Optibiotix.

Yet another bad week, but slightly self-imposed as I cashed in some profits. The deficit between cost and value widened by £3,125 to £96,432 and portfolio value fell to £106,364.

Worst performer was BLU:Blue Star Capital dropping 13% but nothing unusual about that as it goes up and down like a yo-yo, but as the spread is 18% there's no way to take advantage in the short term.

SBTX:SkinBioTherapeutics proves the curse of the trading account, as I only got a small volume in there last week but a lackluster trading statement sent the shares down 13%. My recent £5,000 investment is already losing £1,292 as yet again I get it completely wrong.

CWR:Ceres Power continues the abject misery after declaring the the JV money isn't going to come in this trading year. The price dropped another 12% to go 42% down in about a month.

KIBO:Kibo Energy is a heap of rubbish and fell 11% but it's academic as they are already 100% down.

AJB:AJ Bell is another of my recent investments and dropped 8% this week. However, as I'll be investing monthly for 3 more months, I don't mind if these drop for a while so I get cheaper shares.

FXPO:Ferrexpo fell 7% for no reason.

IES:Invinity Energy also fell 7% for no reason.

Normally I save the biggest riser till last, but SAE:Simec Atlantis Energy climbing 22% is utterly meaningless so I'm getting it out of the way first. My holding is still 87% down.

The only meaningful big risers were metals and mainly gold.

ANTO:Antofagasta rose 5% possibly on the back of copper supply reducing due to problems at one of the world's biggest mines. Strange how that boosted ANTO but not CAML:Central Asia Metals.

POLY:Polymetal climbed 8%, EDV:Endeavour Mining climbed 10% and CEY:Centamin wins Share of the Week climbing 11% as gold had a great rally.

Here's the ISA and shares portfolio after week 18 of year 9.

			Weekly Change
Cash	£165.60		+£0
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£49,696.98	(-49.8%)	-£1,249.55
Potential profits	£2,147.02		-£127.69
Yr 9 Dividends	£147.01		+£0
Yr 9 Interest	£2.46		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£29.42	(0.5%)	-£1.73
Total Dividends	£12,058.44		+£0
Total Interest	£4.39		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£289.11	(4.9%)	-£0.67
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Very little happened. Portfolio value dropped and potential profits down thanks to OPTI:Optibiotix losing 0.5p. Value is down by nearly 50% so I'll have to switch to crimson next week unless we get a turnaround.

The decline has been going on a worrying number of weeks.

Well below the trend line now, so it's getting pulled flatter.

The SIPP looks like this after week 418 overall and week 2 of year 9.

			Weekly Change
Cash	£324.37		-£103.95
Portfolio cost	£101,147.82		+£1,466.88
Portfolio sell value (bid price - commission)	£54,946.72	(-45.7%)	-£1,867.60
Potential profits	£2,340.02		-£1,393.29
Yr 9 Dividends	£13.99		+£0
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£1,362.94		+£1,362.94
Yr 9 proj avg monthly profit	£2,983.34	(52.6%)	+£2,983.34
Total Dividends	£14,648.87		+£0
Total Interest	£5.93		+£0
Total Profit from sales	£12,198.84		+£1,362.94
Average monthly cash profit	£266.39	(4.7%)	+£13.53
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	38%		+2%

Lots going on here. I started off selling my small holding in EDV:Endeavour Mining in my AJ Bell SIPP because I wanted to invest in PAF:Pan African Resources before their dividend date. I sold my 31 shares at 1766.3643 making £52.37 (11.1%) profit. I used the proceeds to buy 3,471 shares in PAF:Pan African Resources at 16.9133p costing £599.95.

I also decided to sell some of my cheap OPTI:Optibiotix shares so I could show a profit. I sold 8,000 at 26.24p after buying at 9.56p and made £1,310.57 (166.1%) profit, liberating £2,087.

Half of it went on more PAF:Pan African Resources. I bought 5,771 but the price had gone up to 17.3278p. That cost £1,016.94. Happy to say the sell price is 17.4p despite going ex-dividend, so these are only down my commission. Let's hope gold stays at the current levels for a while.

The other half of the proceeds went on more JLP:Jubilee Metals as I'm hoping they have finally reached the bottom. I'm still bewildered how they dropped so low. I bought 21,568 at 5.1p costing £1,111.92. The sell price is now up to 5.1p so these are just down on commission. I now hold 213,181 JLP shares, making it my 2nd biggest holding after OPTI:Optibiotix. My hope is that I can take profits and invest them in bigger dividend paying miners in my SIPP and leave the ISA in JLP longer term. I do really need to start moving my SIPP holdings into dividend playing shares and leave the ISA for more risky investments.

The result of the selling activity was a meagre £13 (0.2%) a month increase in long term performance, showing how much profit needs to be made if I want to get back to my 10% target from 4.7%.

I'm less concerned about this chart than the ISA, although it's still pretty bad.

And so we cross the trend line - bugger!

The trading account looks like this after week 384 overall and week 20 of year 8.

			Weekly Change
Cash	£141.20		+£0
Portfolio cost	£1,935.11		+£0
Portfolio sell value (bid price - commission)	£1,089.33	(-43.7%)	-£8.17
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£63.38	(+39.3%)	-£3.34
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.52	(-4.0%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Hardly any change here, with a drop of £8 in value mostly down to SBTX:SkinBioTherapeutics.

Looking very flat

No sign of getting back above the trend line.

It felt great to finally make some profit from my OPTI:Optibiotix holding. Granted it nowhere near makes up for the £56k loss I'm sitting on, in fact it makes that worse, but it is making a start in my strategy to move SIPP shares into dividend-paying companies. At the current rate I have another £1.5k potential profit in my SIPP which would liberate £2.5k for dividend paying shares and not dent my OPTI holding by too much. That would make sense from a risk management point of view, but I'll probably wait until I can liberate £3k.

Week 433 Review - Yet another bad week as the Santa Rally fails to get going.

Lots of drops across the portfolio, with the deficit between cost and value widening by £3,423 to £93,306 and total value at £108,126 

Worst performer was IES:Invinity Energy which seemed to be recovering but has dropped like a stone. This week they fell 15% and are now 87% down.

BLU:Blue Star Capital had another big drop which in combination with last week's drop pretty much wipes out any recent gains.

CWR:Ceres Power lost all last week's gains to drop 7% and go back to a 34% loss.

OPTI:Optibiotix is sliding slowly and fell another 5% this week.

SBTX:SkinBioTherapeutics also fell 5%, which is at least better then the last couple of weeks but still very bad.

JLP:Jubilee Metals had a small recovery of 5% but I'm still losing big on this one.

I hate to say that SAE:Simec Atlantis Energy wins Share of the Week, with a 6% rise. It didn't do much to recover my 89% loss though.

Here's the ISA and shares portfolio after week 17 of year 9.

			Weekly Change
Cash	£165.60		+£0
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£50,946.53	(-48.6%)	-£1,647.16
Potential profits	£2,274.71		-£255.49
Yr 9 Dividends	£147.01		+£0
Yr 9 Interest	£2.46		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£31.15	(0.5%)	-£1.95
Total Dividends	£12,058.44		+£0
Total Interest	£4.39		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£289.78	(4.9%)	-£0.67
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Nothing much to report other than the drop in value and potential profit.

All recent gains have been wiped out.

Well below the rapidly flattening trend line.

The SIPP looks like this after week 417 overall and week 1 of year 9.

			Weekly Change
Cash	£428.33		+£76.51
Portfolio cost	£99,680.94		+£0
Portfolio sell value (bid price - commission)	£55,347.44	(-44.5%)	-£1,779.09
Potential profits	£3,733.31		-£342.04
Yr 9 Dividends	£13.99		+£13.99
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£0	(0%)	+£0
Total Dividends	£14,648.87		+£13.99
Total Interest	£5.93		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£252.86	(4.5%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

I got a tax rebate and £13 dividend from UKW:Greencoat UK Wind, with drops in value and potential profit for the portfolio.

Not so close to the injection line any more.

Just about staying above the trend line.

The trading account looks like this after week 383 overall and week 19 of year 8.

			Weekly Change
Cash	£141.20		-£140.60
Portfolio cost	£1,935.11		+£140.60
Portfolio sell value (bid price - commission)	£1,097.50	(-43.3%)	+£3.23
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£66.72	(+41.4%)	-£3.71
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.54	(-4.1%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

I was eligible for the retail offer in SBTX:SkinBiotherapeutics so was allowed to buy 740 shares at 19p costing £140.60. I figured it was worth it in my trading account as there's no commission. I very much doubt I'll get a quick reward though, as the share price is dropping down to the retail offer price. Sell value increased by £3 (not including the increase in cost from the purchase)

The green line includes cash, which is why that stayed level as costs went up.

At least it didn't go down...

That's the holiday period caught up - looking forward to reporting on some profits and new purchases at the end of this week.

Week 432 Review - A great week for most shares, but my biggest holdings drop.

It wasn't a bad week for most shares, but some of my biggest holdings fell and so the deficit between cost and value widened by £1,421 to £89,883 and total value dropped to £111,473.

Worst performer was BLU:Blue Star Capital which lost half of last week's inexplicable gains and dropped 18%.

SBTX:SkinBioTherapeutics fell another 13% as my recent investment is decimated.

KIBO:Kibo Energy dropped 10% and I'm sure will never recover from the current 100% loss.

On the brighter side, ASHM:Ashmore Group recovered from an utterly miserable few months by rising 6%, but is still 40% down.

BARC:Barclays also rose 6% but is still 14% down in my trading account.

CEY:Centamin responded to the increase in gold price better than EDV:Endeavour Mining and climbed 6% to go 24% down.

PAGE:Page Group keep flirting with going into profit, and climbed 6% to go only 5% down. Will I be able to bed them into my ISA soon without having to record a paper loss?

ANTO:Antofagasta went up 7% and are now only 9% down so also getting towards profitability.

CAML:Cental Asia Metals are now one of my larger holdings and climbed 7% so my most recent purchase is only 1% down.

CWR:Ceres Power are so volatile, but this week in the right direction as they increased 7%.

III:3i Group have been a rare example of a successful magic formula share, and rose 7% to go 33% up.

Share of the Week is PSN:Persimmon which climbed 8% for no reason I could detect, and are now only 15% down.

Here's the ISA and shares portfolio after week 16 of year 9.

			Weekly Change
Cash	£165.60		-£3.80
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£52,593.69	(-46.9%)	-£1,152.08
Potential profits	£2,530.20		-£256.14
Yr 9 Dividends	£147.01		+£0.11
Yr 9 Interest	£2.46		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£33.10	(0.6%)	-£8.91
Total Dividends	£12,058.44		+£0.11
Total Interest	£4.39		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£290.45	(4.9%)	-£2.07
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Not much going on. The 11p dividend was a fractional sum following the share consolidation at RDT:Rosslyn Data and is probably the only return I will ever get from that investment.

The decline continues

Touching the trend line but not below it

The SIPP looks like this after week 416 overall and week 52 of year 8.

			Weekly Change
Cash	£351.82		-£1.44
Portfolio cost	£99,680.94		+£0
Portfolio sell value (bid price - commission)	£57,126.53	(-42.7%)	-£281.81
Potential profits	£4,075.35		+£4.32
Yr 8 Dividends	£492.10		+£0
Yr 8 Interest	£5.68		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£771.75	(-13.6%)	+£15.01
Total Dividends	£14,634.88		+£0
Total Interest	£5.93		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£253.55	(4.5%)	-£0.62
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Much smaller losses in this account thanks to the gains in other stocks.

Looks nice and flat. Still encouragingly close to the injection line.

Still above the trend line - yippee!

The trading account looks like this after week 382 overall and week 18 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£953.67	(-46.9%)	+£12.65
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£70.43	(+47.1%)	-£4.14
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.56	(-4.4%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

A rare increase in value!

Have we bottomed out?

Still a long way to go to recover.

That's 2 out of 3 weeks caught up. One more to go...

Week 431 Review - Dreadful week as all my large holdings drop

A pretty bad week for almost everything, with the gap between cost and value widening by £3,268 to £88,462 and total value dropping to £112,899.

Worst performer was SBTX:SkinBioTherapeutics which fell 15%, which is deeply upsetting after my recent big purchase.

CWR:Ceres Power has been an utter disaster and fell another 14% to go 33% down in just a few weeks.

JLP:Jubilee Metals is one of my largest holdings and continues to drop, this week by 6% to go below 5p.

SAE:Simec Atlantis Energy also fell 6% for no particular reason.

ANTO:Antofagasta dropped 5% to go 15% down.

EDV:Endeavour Mining also dropped 5% but fortunately my recent purchase is still just in profit.

OPTI:Optibiotix continued to slide with another 5% drop contributing to much of the losses this week.

Only one share rose more than 5% so BLU:Blue Star Capital gets Share of the Week rising 38%, but I suspect it's just shorts closing as there's no reason for it to go up.

Here's the ISA and shares portfolio after week 15 of year 9.

			Weekly Change
Cash	£169.40		+£26.58
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£53,745.77	(-45.8%)	-£3,268.08
Potential profits	£2,786.34		-£1,142.87
Yr 9 Dividends	£146.90		+£25.71
Yr 9 Interest	£2.46		+£0.87
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£42.01	(0.7%)	+£6.10
Total Dividends	£12,058.33		+£25.71
Total Interest	£4.39		+£0.87
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£292.52	(5.0%)	-£0.42
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I received a £25 dividend from PLUS:Plus 500 and 87p interest. Big drop in portfolio value and most of reduced potential profits were due to OPTI:Optibiotix.

Hope this doesn't become a trend!

Almost down to the trend line - let's hope we don't cross it

The SIPP looks like this after week 415 overall and week 51 of year 8.

			Weekly Change
Cash	£353.26		+£0.46
Portfolio cost	£99,680.94		+£249.92
Portfolio sell value (bid price - commission)	£57,408.34	(-42.7%)	-£2,542.45
Potential profits	£4,071.03		-£358.24
Yr 8 Dividends	£492.10		+£0
Yr 8 Interest	£5.68		+£0.46
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£786.76	(-13.9%)	+£15.77
Total Dividends	£14,634.88		+£0
Total Interest	£5.93		+£0.46
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£253.95	(4.5%)	-£0.61
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Similar story to the ISA except with no dividend. My regular investment went through, purchasing 91 shares in AJB:AJ Bell at 271.6296p costing £249.92. Just one more week to go and I'll be able to wave goodbye to the depressing DDDD:4D Pharma loss haunting me every week for Year 8.

Seems less of a drop than the ISA

A little more of a buffer to the trend line than the ISA

The trading account looks like this after week 381 overall and week 17 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£941.02	(-47.6%)	-£24.21
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£74.57	(+49.9%)	-£4.66
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.57	(-4.4%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Yet another drop. Nothing more to say.

Long term decline.

I'm amazed the trend line isn't flatter by now, but I can't see a £300 reversal in fortune to get back anywhere near it, so it will flatten quickly.

This was a catch up from when I was on hols and managed to take the weekly snapshots. Another 2 weeks of catch-ups to write before we're up to date...

Week 430 Review - A great week ruined by big drops for Optibiotix and Jubilee Metals

Deeply upsetting that over the best couple of days for a long time across my portfolio, big drops in both OPTI:Optibiotix and JLP:Jubilee Metals caused the deficit between cost and value to widen by £7,184 to £82,627 and portfolio value fell to £118,457.

Worst performer was OPTI:Optibiotix which dropped 3p and 9%. I guess after last week's 25% rise it's not a huge surprise, but was so disappointing when everything else was doing so well.

BLU:Blue Star Capital is highly volatile and gave up the 6% rise from last week.

POLY:Polymetal was a surprise, dropping by 6% when other gold miners did well.

JLP:Jubilee Metals is one of my biggest holdings, so a 5% drop this week continues their inexplicable fall. I took the opportunity to buy some more.

Now for the very extensive good news.

BARC:Barclays recovered from last week's 11% drop by climbing 5%, but they are still 18% down.

EDV:Endeavour Mining has been a bit dreadful recently, but also climbed 5% and leaves my recent purchases 9% up.

GAW:Games Workshop slumped recently from their price a few months ago, but a 5% climb this week put my holding 7% up. It's a long way back to the 20% gains I had before their stellar results though.

IGG:IG Group have been drifting horribly, and I still don't understand why. This week they went up 6% but are still 26% down.

IES:Invinity Energy usually needs news to shift the price up, but this week climbed 6% without any. They are still an eye-watering 83% down, but given I thought they would go bust I guess it's a bonus they still exist.

ASHM:Ashmore Group have been drifting for a long time, but bounced back 7% this week. They are 36% down so a long way to go to break even.

CEY:Centamin was my best gold mine this week, climbing 8% but still 27% down.

PAGE:Page Group plummeted after results a few weeks ago, but fought back 12% this week and are now only 12% down. I still have these in my dealing account and want them to get into profit before I bed and ISA them.

PSN:Persimmon have also been really struggling lately, but went up 13% this week and are now 24% down.

WHR:Warehouse REIT have also been really bad lately, but they bounced back 15% and are now 27% down.

Share of the Week is CWR:Ceres Power which has been my worst timed purchase ever, as it has crashed every week since. This week it clawed back 18% of those losses but is still 22% down. Hopefully this will continue, but it's going to take news of their Chinese joint venture being approved to get any meaningful recovery.

Here's the ISA and shares portfolio after week 14 of year 9.

			Weekly Change
Cash	£142.82		-£98.24
Portfolio cost	£99,082.34		+£599.99
Portfolio sell value (bid price-commission)	£57,013.85	(-42.5%)	-£3,377.57
Potential profits	£3,929.21		-£873.20
Yr 9 Dividends	£121.19		+£5.50
Yr 9 Interest	£1.59		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£35.91	(0.6%)	-£2.57
Total Dividends	£12,032.62		+£5.50
Total Interest	£3.52		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£292.94	(5.0%)	-£0.66
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I added £150 following a premium bond win, and topped that up with another £350 and transferred £100 dividends from my dealing account to my ISA. That allowed me to buy 11,135 shares in JLP:Jubilee Metals at 5.299p costing £599.99. It reduced my average price in my AJ Bell ISA to 6.96p, and with that holding containing 66,947 shares, if it gets back to 12p like a few months ago I'll be over £3,000 in profit for that holding. I really think it should be back there before Christmas, but I never expected it to fall this low.

Portfolio value gave up almost half last week's gains thanks to OPTI:Optibiotix and JLP:Jubilee Metals, and potential profits dropped £873 thanks to OPTI:Optibiotix. A £5 dividend from GAW:Games Workshop was nice, if a tad stingy.

I suppose I should expect a bit of a pull back after last week being so great.

Unfortunately we're going back towards the trend line, but happy to be still above it.

The SIPP looks like this after week 414 overall and week 50 of year 8.

			Weekly Change
Cash	£352.80		-£160.87
Portfolio cost	£99,431.02		+£2,408.21
Portfolio sell value (bid price - commission)	£59,700.87	(-40.0%)	-£3,806.93
Potential profits	£4,429.27		-£788.62
Yr 8 Dividends	£492.10		+£14.00
Yr 8 Interest	£5.22		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£802.53	(-14.2%)	+£16.14
Total Dividends	£14,634.88		+£14.00
Total Interest	£5.47		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£254.56	(4.5%)	-£0.65
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		-1%

I had my £2,000 pension transfer to invest this week, so immediately bought 733 shares in CAML:Central Asia Metals at 163.5118p and costing £1,210.49. I'll keep buying more of these while they remain so cheap, as they have no debt, bucket loads of cash, and a massive dividend.

I managed to find a new source of stats for my magic formula spreadsheet, and whacked in the data for the top 170 and ranked them. I had to change a few of the stats I use, but I think they still give a similar impression of the company. I still use dividend yield as the first ranking criteria, but I had to change ROCE to return on investment, and had to change debt to pre-tax profits ratio to debt to equity ratio. Not ideal but still a good impression of the sustainability of their debt. The 3 year growth had to change to 5 year growth, which still gives a good idea of how they are growing, although misses recent good performance if they had a few bad years before that.

When I ranked my top 100 it made quite a few changes, but by far the top company was PLUS:Plus 500 so I bought 69 shares at 1428.6949p costing £997.75. I already hold these, but I think increasing my holding in some of the companies I already know well is better then trying new ones.

SQZ:Serica Energy came 2nd, but I'm not investing in oil companies. IPX:Impax Asset Management Group were 3rd, so I may take a look at those. POLR:Polar Capital Holdings is 4th, and one I have held in the past. HL.:Hargreaves Lansdown is 5th and may be worth a look as I do have an account with them.

Some of my existing holdings are still in the top 10, with III:3i Group 6th and PAGE:Page Group 8th. GAW:Games Workshop is 11th. The others are less impressive, with IGG:IG Group Holdings 22nd and RIO:Rio Tinto 23rd, but both are in the top 30 which is my criteria for keeping them.

CAML:Central Asia Metals is 34th, which isn't too bad, PSN:Persimmon is 43rd, UKW:Greencoat UK Wind 44th, CEY:Centamin 46th, ANTO:Antofagasta 53rd, APAX:Apax Global Alpha 61st, ASHM:Ashmore Group 66th, CAPD:Capital 71st, FXPO:Ferrecpo 79th, WHR:Warehouse REIT 134th and most disappointingly EDV:Endeavour Mining 145th.  

It means I should be selling the companies outside the top 30 and replacing them with companies higher up the ranking, but all of them are making a loss. I will flag them for removal should an opportunity arise.

I also bought 3,586 shares in JLP:Jubilee Metals in my AJ Bell account with some dividend money. I paid 5.299p and they cost £199.97. I don't usually like buying for less than £500 because of the commission, but as I'm adding to my existing holding, the sell commission will be shared and I'm hoping they will go up sharply soon.

I got a £14 dividend from PSN:Persimmon, and value and potential profits are down for the same reasons as the ISA.

Sad to see the green line point down when the red and orange point up.

Sharp drop towards the trend line

The trading account looks like this after week 380 overall and week 16 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£965.23	(-46.2%)	-£0.44
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£79.23	(+53.0%)	-£5.28
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.59	(-4.4%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

BARC:Barclays went up really well but JLP:Jubilee Metals went down, so they cancelled each other out and I lost 44p.

Nice to at least stop the rot.

Way below the trend line which will start to flatten unless I can get back up above it.

What makes this week even more depressing is that the drop in OPTI:Optibiotix came on the back of an encouraging commercial update. Every time I think things are turning round, the price drops yet again, and for my biggest holdings to drop significantly in such a good week is very frustrating.

No blog for the next couple of weeks as I'll be on hols but will aim to get a snapshot each week so I don't lose any stats and can do a bumper catch-up when I get back.